Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Microbiological Services
    • Foods/Beverages/Food Ingredients
    • Pharmaceutical Microbiology
    • Water/Wastewater
  • Analytical Chemistry Services
    • Food Chemistry
    • Pharmaceutical Chemistry
  • R&D Services
    • Research and Development Laboratory Services
  • Technical Capabilities
  • Newsletter
    • Food Newsletter
    • Pharma/Cosmetic/OTC Newsletter
    • Newsletter Archives
  • Blog
  • About
    • Why Choose Q Laboratories
    • History of Q Laboratories
    • Frequently Asked Questions
  • Careers
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Microbiological Services
    • Foods/Beverages/Food Ingredients
    • Pharmaceutical Microbiology
    • Water/Wastewater
  • Analytical Chemistry Services
    • Food Chemistry
    • Pharmaceutical Chemistry
  • R&D Services
    • Research and Development Laboratory Services
  • Technical Capabilities
  • Newsletter
    • Food Newsletter
    • Pharma/Cosmetic/OTC Newsletter
    • Newsletter Archives
  • Blog
  • About
    • Why Choose Q Laboratories
    • History of Q Laboratories
    • Frequently Asked Questions
  • Careers

Reprocessing of Reusable Medical Devices

  • Posted by Mark Goins
  • On January 10, 2017
  • microbiology
The FDA requires manufacturers of reusable medical devices to provide reprocessing instructions that ensure that the device can be used safely and for the purpose for which it is intended. Developing and validating these instructions can be a complex and highly specialized activity. Guidance on this process can be found in a document created by the FDA Center for Devices and Radiological Health entitled, “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Guidance for Industry and Food and Drug Administration Staff.” The guidance indicates, the labeling of a reusable medical device should clearly specify the appropriate material and equipment parameters to adequately reprocess the devices.  Reprocessing is defined as validated processes used to render a medical device, which has been previously used or contaminated, fit for a subsequent single use. These processes are designed to remove soil and contaminants by cleaning and to inactivate microorganisms by disinfection. The validation of the cleaning and disinfection process may also be a necessary part of Premarket Notification - also called PMN or 510(k). (more…)
 

Low Moisture Foods Prove Problematic

  • Posted by Mark Goins
  • On December 27, 2016
  • low moisture foods
While traditionally considered low risk, low moisture foods are susceptible to pathogen contamination as evidenced by recent cases of Salmonsalmonellaella contamination in dairy powder, paprika powder, black pepper, toasted oats cereal, peanut butter, and chia powder. Research has shown that while pathogens do not thrive in low moisture foods, they do survive very well in these dry environments when stored at room temperature or above.  In the cases when the low moisture products are reconstituted, the bacteria proliferate when the moisture level is increased.  Bacterial strains that survive in these dry products have proven to withstand low pH environments, such as the stomach, and therefore reach the intestines where they cause the most problems for the consumer. Due to their benign reputation, low moisture foods are often left off the list of matrices validated when rapid pathogen detection products are developed and approved. Therefore, a qualified laboratory must perform a validation study to indicate proficiency of a rapid method for these troublesome product types.  
 

Microbial Identification Capabilities

  • Posted by Mark Goins
  • On December 15, 2016
  • microbial identification
Q Laboratories, Inc. has added another tool to our microbial identification capabilities by acquiring the Bruker MALDI Biotyper®. This technology allows for rapid, cost-effective, accurate identification of thousands of microorganisms (including yeasts and filamentous fungi) using state-of-the-art technology. It can be used for environmental, product and/or research and development applications. Classification and identification are based on proteomic fingerprinting using high-throughput mass spectrometry. Turnaround time can be as little as one day.

Currently celebrating 50 years in business, Q Laboratories, Inc has recently opened a new dedicated microbial identification laboratory as part of our ongoing facility expansion. This space will house the Bruker MALDI Biotyper® as well as traditional biochemical identification technology and will allow for additional microbial identification capability in the future.

bruker
 

Restaurant Labeling Provision in Limbo

  • Posted by Mark Goins
  • On December 6, 2016
  • menu labeling, obamacare
Post-election angst about the future of the Affordable Care Act (ACA), aka Obamacare, has spilled over into the food/restaurant industry. Since the new Menu Labeling requirements for restaurants with 20 or more units, as well as rules for vending machines and supermarkets that serve ready-to-eat food, are part of the ACA, industry stakeholders are anxiously awaiting whether the new administration is going to repeal the law completely, replace it or make line-item changes to the ACA. Restaurants that have been performing due diligence to get their ducks in a row for providing nutritional information about their menu items are now wondering if all their efforts were for naught, or if another provision is coming, and if so what are the requirements. Stay tuned for more on this ever-changing issue.
 

Is it a Cosmetic or a Drug…..or Both

  • Posted by Mark Goins
  • On December 2, 2016
  • fd&c act, FDA
The Federal Food, Drug, and Cosmetic Act (FD&C Act) defines cosmetics by their intended use, as "articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance" [FD&C Act, sec. 201(i)]. Among the products included in this definition are skin moisturizers, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, cleansing shampoos, permanent waves, hair colors, and deodorants, as well as any substance intended for use as a component of a cosmetic product. The FD&C Act defines drugs, in part, by their intended use, as "articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease" and "articles (other than food) intended to affect the structure or any function of the body of man or other animals" [FD&C Act, sec. 201(g)]. Some products meet the definitions of both cosmetics and drugs. This may happen when a product has two intended uses. For example, a shampoo is a cosmetic because its intended use is to cleanse the hair. An antidandruff treatment is a drug because its intended use is to treat dandruff. Consequently, an antidandruff shampoo is both a cosmetic and a drug. Among other cosmetic/drug combinations are toothpastes that contain fluoride, deodorants that are also antiperspirants, and moisturizers and makeup marketed with sun-protection claims. Such products must comply with the requirements for both cosmetics and drugs.
 
  1. Pages:
  2. «
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. »
Page 6 of 7«‹4567›
« Previous 1 … 4 5 6 7 Next »
Follow Us!
Follow Us on FacebookFollow Us on TwitterFollow Us on LinkedInFollow Us on InstagramFollow Us on Google+
Recent Posts
  • To CFU or Not CFU – Probiotics Enumeration
  • Stability Testing for Pharmaceuticals
  • Q Laboratories Becomes First U.S. Lab with Food Virus Testing Accreditation
  • Q Laboratories’ Collaboration Recognized for Excellence
  • Q Laboratories Cuts Ribbon on New Building

Categories
  • 510(k)
  • Affordable Care Act
  • AFNOR
  • AOAC
  • Company News
  • cosmetics
  • dietary supplements
  • drugs
  • Environmental Monitoring
  • facility management
  • FDA
  • Food
  • Food Safety
  • Food Safety Modernization Act
  • FSMA
  • health and beauty care
  • health care facilities
  • healthcare
  • hepatitis A
  • Industry News
  • Laboratory News
  • Legionella
  • MBC
  • medical devices
  • MIC
  • microbiology
  • MicroVal
  • Minimum Bactericidal Concentration
  • Minimum Inhibitory Concentration
  • norovirus
  • nutritional analysis
  • pathogen detection
  • Pet Food
  • pharmaceuticals
  • Pharmacopeia
  • probiotics
  • restaurants
  • Salmonella
  • sunscreens
  • Updates
  • validation
  • verification
  • Virus Detection
  • Water microbiology
Archives
  • October 2018
  • August 2018
  • June 2018
  • May 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
Scroll

Q Laboratories

1930 Radcliff Drive
Cincinnati, Ohio 45204-1823
Phone Icon
(513) 471-1300
Fax Icon
(513) 471-5600
Mail Icon
office@qlaboratories.com

cGMP/GLP Compliant

FDA Registered (Reg. #1527260)

CDC ELITE Certified for Legionella Analysis in Water

EPA/DDGW Certified for Potable Water Microbiological Testing

Q Laboratories, Inc. BBB Business Review
@ Q Laboratories
Design: webFEAT complete | Privacy Policy